Canonical: https://ownershiptrace.com/13f/companies/3322

# Who owns Roivant Sciences Ltd. (ROIV)? Elite investor 13F holders

7 tracked elite investors reported holding Roivant Sciences Ltd as of 2026-06-30, including Viking Global Investors, Rubric Capital, D.E. Shaw, Maverick Capital, Greenlight Capital. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Viking Global Investors](https://ownershiptrace.com/13f/investors/81) | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 221947217.00 USD | 6271467.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1103804/0001103804-26-000006-index.html) |
| [Rubric Capital](https://ownershiptrace.com/13f/investors/120) | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 212340000.00 USD | 6000000.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1687509/0001104659-26-097098-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 105203924.00 USD | 2972702.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Maverick Capital](https://ownershiptrace.com/13f/investors/50) | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 100119159.00 USD | 2829024.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/934639/0000947871-26-000793-index.html) |
| [Greenlight Capital](https://ownershiptrace.com/13f/investors/24) | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 76182956.00 USD | 2152669.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1489933/0001172661-26-003786-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 47757566.00 USD | 1349465.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Polen Capital Management](https://ownershiptrace.com/13f/investors/61) | ROIVANT SCIENCES LTD | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 306442.00 USD | 8659.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1034524/0001172661-26-003035-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)